Abstract: METHODS: We constructed a series of
HBx mutants with changes in the
CP region that correspond to
A1762T/
G1764A (TA),
T1753A,
T1768A, or a combination of these (combo) and expressed them, along with wild-type
HBx under control of its endogenous promoter, in primary human hepatocytes (PHHs) and HepG2 cells.
Introduction: Clinical studies have shown that the common double mutation
A1762T/
G1764A (TA) in the HBV
basal core promoter (
CP) region is independently associated with
HCC.